Cilfa Opposition, 1 1 Beta Hydroxysteroid Dehydrogenase 1 , (Ar090999 A1)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
CILFA opposition, tobramycin, (AR092318A1)
Countries: Argentina Date: 2015
-
CILFA opposition, metformin, simvastatin or atorvastatin,benazepril, lisinopril or losartan, aspirin, (AR091739A1)
Countries: Argentina Date: 2015
-
CILFA opposition, agomelatine, (AR095152A1)
Countries: Argentina Date: 2015
-
CILFA opposition, lactoferrin, (AR093894A1)
Countries: Argentina Date: 2015
-
CILFA opposition, montelukast and levocetirizine, (AR087177A1)
Countries: Argentina Date: 2015
-
CILFA opposition, ranibizumab and bevacizumab, (AR092372A1)
Countries: Argentina Date: 2015
-
CILFA opposition, levothyroxine, (AR092151A1)
Countries: Argentina Date: 2015
-
CILFA opposition, mesalazine, (AR108231A1)
Countries: Argentina Date: 2018
-
CILFA opposition, estradiol, (AR107022A1)
Countries: Argentina Date: 2019
-
CILFA opposition, fenibrutinib, (AR107751A1)
Countries: Argentina Date: 2018